Ann Integrative Oncol | Volume 1, Issue 1 | Short Communication | Open Access

CRISPR/Cas9 and Disease-Specific, Precision-Drugs Development

Karal Petrak

Karal Petrak, NangioTx Inc., 1180 Raymond Blvd, Newark, NJ 071024113, USA, Tel: 6786131386.

*Correspondance to: Karal Petrak 

Fulltext PDF

Abstract

#

Keywords:

#

Citation:

Petrak K. CRISPR/Cas9 and DiseaseSpecific, Precision-Drugs Development. Ann Integr Oncol. 2020; 1(1): 1003..

Subscribe to Our Newsletter